The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study to evaluate safety and efficacy of neoadjuvant pembrolizumab and radiotherapy in localized MSS rectal cancer.
 
Thibaud Kossler
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Merck; Merck; Merck; Merck
Travel, Accommodations, Expenses - Ipsen; Ipsen; Ipsen; Ipsen; Sanofi; Sanofi; Sanofi; Sanofi
 
Buchs Nicolas
No Relationships to Disclose
 
Valérie Dutoit
Research Funding - Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme
 
Giacomo Puppa
No Relationships to Disclose
 
Petros Tsantoulis
No Relationships to Disclose
 
Jean-Louis Frossard
No Relationships to Disclose
 
Philippe Bichard
No Relationships to Disclose
 
Xavier Montet
No Relationships to Disclose
 
Thomas McKee
Speakers' Bureau - Novartis; Novartis; Novartis; Novartis
Travel, Accommodations, Expenses - Roche; Roche; Roche; Roche
 
Mariagrazia Di Marco
No Relationships to Disclose
 
Pierre-Yves Dietrich
Research Funding - Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme
 
Arnaud Roth
No Relationships to Disclose
 
Thomas Zilli
No Relationships to Disclose
 
Frédéric Ris
No Relationships to Disclose